BioCryst Pharma (BCRX) Continues Higher Following Speculation of Ebola Cure
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St slips on rising bond yields; Walmart results weigh
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Ebola Stocks Gain as Death Toll Reaches 826 (TKMR) (BCRX) (NNVC)
August 4, 2014 9:39 AM EDTEbola stocks are gaining momentum today, with three names on traders radars: Tekmira Pharmaceuticals Corp (Nasdaq: TKMR) (+14.5%), BioCryst Pharmaceuticals (Nasdaq: BCRX) (+4.2%), NanoViricides, Inc. (NYSE: NNVC) (+4.6%).
Approximately 826 people have died from Ebola virus in the current epidemic. Two US health care workers, a doctor and a nurse, also contracted ebola infection.
... MoreTekmira Pharmaceuticals (TKMR) Stock Quietly Gains Steam on Ebola Outbreak
July 31, 2014 1:55 PM EDTWhile the Ebola outbreak in Africa has grabbed the mainstream headlines, traders in the stock market have been more subdued in their response - unlike bird-flu, swine-flu and SARS stock market hype of the past. However, one stock appears to be quietly gaining momentum on the headlines - Tekmira Pharmaceuticals Corporation (NASDAQ: TKMR).
While a recent clinical study for Tekmira's Ebola virus RNAi therapeutic, TKM-Ebola, was placed on clinical hold by the FDA, some still see the stock as a great way to gain exposure to the Ebola... More
